SCHEMBL29318841

SCHEMBL29318841

COc1ccc(COc2c(F)cc(C(=O)NC[C@H]3CC[C@H](C(=O)OC)CC3)c(F)c2F)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.42
GNRHR P30968 1/20 0.42
ALDH1A1 P00352 2/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
GSK3B P49841 3/20 0.40
F10 P00742 1/20 0.40
ALDH2 P05091 1/20 0.39
HTR4 Q13639 1/20 0.39
CXCR3 P49682 1/20 0.39
LMNA P02545 1/20 0.39
HPGD P15428 1/20 0.39
CNR2 P34972 1/20 0.38
PDE4A P27815 1/20 0.38
PDE4B Q07343 1/20 0.38
PDE4C Q08493 1/20 0.38
PDE4D Q08499 1/20 0.38
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
BLM P54132 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30970080 1.00 POLB (0.42) POLBGNRHRALDH1A1NPC1RAB9A
SCHEMBL29318867 0.95 POLB (0.41) POLBGNRHRALDH1A1NPC1RAB9A
SCHEMBL30970111 0.95 POLB (0.41) POLBGNRHRALDH1A1NPC1RAB9A
SCHEMBL29318839 0.93 MEN1 (0.44) POLBALDH1A1NPC1RAB9AGSK3B
SCHEMBL30995319 0.93 MEN1 (0.44) POLBALDH1A1NPC1RAB9AGSK3B
SCHEMBL29318864 0.92 POLB (0.42) POLBGNRHRALDH1A1NPC1RAB9A
SCHEMBL30995292 0.92 POLB (0.42) POLBGNRHRALDH1A1NPC1RAB9A
SCHEMBL27390793 0.90 POLB (0.43) POLBALDH1A1NPC1RAB9AGSK3B
SCHEMBL29318811 0.90 POLB (0.43) POLBALDH1A1NPC1RAB9AGSK3B
SCHEMBL27347826 0.90 POLB (0.54) POLBALDH1A1NPC1RAB9AF10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240238425-A1 HSD17B13 Inhibitors and/or Degraders PFIZER INC. (US) 2024-07-18 US disclosed
US-20240238425-A1 HSD17B13 Inhibitors and/or Degraders PFIZER INC. (US) 2024-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240238425-A1 HSD17B13 Inhibitors and/or Degraders HSD17B13, HSD17B3, HSD17B1 POLB 462/4885GNRHR 1772/4885ALDH1A1 98/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.